Home

Thursday, November 16, 2017 - 12:37
China Regenerative Medicine International (CRMI) has acquired Obagi Medical Products from Valeant Pharmaceuticals for $190 million in cash. CRMI, which operates seven production plants in mainland China and Hong Kong, specializes in the research, development and commercialization of innovative bio-medical, healthcare products and medical techniques. In a press release, the company noted that this acquisition will help pave the way for future development of its cosmeceutical business in both the U.S. and international markets.
https://www.medestheticsmag.com/crmi-acquires-obagi-medical
Thursday, November 16, 2017 - 12:37
China Regenerative Medicine International (CRMI) has acquired Obagi Medical Products from Valeant Pharmaceuticals for $190 million in cash. CRMI, which operates seven production plants in mainland China and Hong Kong, specializes in the research, development and commercialization of innovative bio-medical, healthcare products and medical techniques. In a press release, the company noted that this acquisition will help pave the way for future development of its cosmeceutical business in both the U.S. and international markets.
https://www.medestheticsmag.com/crmi-acquires-obagi-medical
Thursday, November 16, 2017 - 12:35
Obesity is associated with an increased risk of rosacea in women, according to a new study published in the December 2017 issue of the Journal of the American Academy of Dermatology. Authors Suyun Li, PhD, et al, identified 5,249 cases of rosacea diagnosed from 1991-2005 among 89,886 women who participated in the Nurses’ Health Study II. They found significant correlation between rosacea risk and higher body mass index (≥35), particularly among those who had gained weight after age 18.
https://www.medestheticsmag.com/obesity-and-waist-circumference-risk-factors-rosacea

Advertisement - Box 1

Advertisement - Box 2

Thursday, November 16, 2017 - 12:35
Obesity is associated with an increased risk of rosacea in women, according to a new study published in the December 2017 issue of the Journal of the American Academy of Dermatology. Authors Suyun Li, PhD, et al, identified 5,249 cases of rosacea diagnosed from 1991-2005 among 89,886 women who participated in the Nurses’ Health Study II. They found significant correlation between rosacea risk and higher body mass index (≥35), particularly among those who had gained weight after age 18.
https://www.medestheticsmag.com/obesity-and-waist-circumference-risk-factors-rosacea
Thursday, November 16, 2017 - 12:33
Kate Ricciardi has been hired as the new marketing project manager for skincare manufacturer Skinprint. Ricciardi is a recent graduate of Hofstra University. She received her Bachelor of Arts degree in Broadcast Journalism with a minor in Public Relations and worked as an intern with CBS News and the International Academy of Television Arts and Sciences. In addition to developing and executing all e-commerce projects, Ricciardi will be responsible for the company’s website (skinprint.com) and all social media campaigns.
https://www.medestheticsmag.com/skinprint-names-kate-ricciardi-new-marketing-project-manager
Thursday, November 16, 2017 - 12:33
Kate Ricciardi has been hired as the new marketing project manager for skincare manufacturer Skinprint. Ricciardi is a recent graduate of Hofstra University. She received her Bachelor of Arts degree in Broadcast Journalism with a minor in Public Relations and worked as an intern with CBS News and the International Academy of Television Arts and Sciences. In addition to developing and executing all e-commerce projects, Ricciardi will be responsible for the company’s website (skinprint.com) and all social media campaigns.
https://www.medestheticsmag.com/skinprint-names-kate-ricciardi-new-marketing-project-manager

Advertisement - Box 3

Advertisement - Box 4

Thursday, November 16, 2017 - 12:30
A new neurotoxin with a fast onset of action and shorter duration of effect is in development for aesthetics and pain relief.By Inga HansenWhile the aesthetics industry has been focused on new botulinum toxin products and dosing strategies geared toward increasing longevity of results, a new company Bonti has been developing EB-001, a serotype E botulinum toxin that moves in the opposite direction. “This molecule is very similar to the existing botulinum toxin serotype A products in terms of mechanism of action, however, it has two differentiating factors.
https://www.medestheticsmag.com/no-pain-swift-gains
Thursday, November 16, 2017 - 12:30
A new neurotoxin with a fast onset of action and shorter duration of effect is in development for aesthetics and pain relief.By Inga HansenWhile the aesthetics industry has been focused on new botulinum toxin products and dosing strategies geared toward increasing longevity of results, a new company Bonti has been developing EB-001, a serotype E botulinum toxin that moves in the opposite direction. “This molecule is very similar to the existing botulinum toxin serotype A products in terms of mechanism of action, however, it has two differentiating factors.
https://www.medestheticsmag.com/no-pain-swift-gains
Monday, November 13, 2017 - 15:59
Three color cosmetic innovators discussed the category's growth at the event on November 9th.On November 9 at the historic Jonathan Club in downtown Los Angeles, CEW’s West Coast chapter held Beauty’s Color Quake—a panel discussion about the factors that have fueled the recent boom in color cosmetics lead by WWD’s Marcy Medina. The event brought together speakers Rea Ann Silva, the president and owner of Rea.Deeming Beauty Inc.
https://www.beautystorebusiness.com/industry-experts-unite-cew-beautys-color-quake-event

Pages

Advertisement - Box 5

Advertisement - Box 6